S'abonner

Effect of salidroside on neuroprotection and psychiatric sequelae during the COVID-19 pandemic: A review - 05/01/24

Doi : 10.1016/j.biopha.2023.115999 
Ting Zhu a, 1, Hui Liu e, f, 1, Shiman Gao g, Ning Jiang c, , Shuai Chen d, , Weijie Xie b,
a Institute of Neuroregeneration & Neurorehabilitation, Department of Pathophysiology, School of Basic Medicine, Qingdao University, Qingdao 266071, China 
b Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, Tongji University School of Medicine, Shanghai 200122, China 
c Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China 
d School of Public Health, Wuhan University, Donghu Road No. 115, Wuchang District, Wuhan 430071, China 
e Guizhou Provincial Key Laboratory of Pharmaceutics & State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550004, Guizhou, China 
f Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, Guizhou, China 
g Department of Clinical Pharmacy, Women and Children’s Hospital, Qingdao University, Qingdao 266034, China 

Corresponding authors.⁎⁎Correspondence to: Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, Tongji University School of Medicine, Shanghai, China.Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, Tongji University School of MedicineShanghaiChina

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has affected the mental health of individuals worldwide, and the risk of psychiatric sequelae and consequent mental disorders has increased among the general population, health care workers and patients with COVID-19. Achieving effective and widespread prevention of pandemic-related psychiatric sequelae to protect the mental health of the global population is a serious challenge. Salidroside, as a natural agent, has substantial pharmacological activity and health effects, exerts obvious neuroprotective effects, and may be effective in preventing and treating psychiatric sequelae and mental disorders resulting from stress stemming from the COVID-19 pandemic. Herein, we systematically summarise, analyse and discuss the therapeutic effects of salidroside in the prevention and treatment of psychiatric sequelae as well as its roles in preventing the progression of mental disorders, and fully clarify the potential of salidroside as a widely applicable agent for preventing mental disorders caused by stress; the mechanisms underlying the potential protective effects of salidroside are involved in the regulation of the oxidative stress, neuroinflammation, neural regeneration and cell apoptosis in the brain, the network homeostasis of neurotransmission, HPA axis and cholinergic system, and the improvement of synaptic plasticity. Notably, this review innovatively proposes that salidroside is a potential agent for treating stress-induced health issues during the COVID-19 pandemic and provides scientific evidence and a theoretical basis for the use of natural products to combat the current mental health crisis.

Le texte complet de cet article est disponible en PDF.

Abbreviations : α-syn, ACTH, AD, AMPK, APP, BACE1, BBB, BDNF, CAM, CIRI, CMS, COVID-19, CORT, CRH, CREB, DA, DJ-1, ER, GCLc, GPCR, GPx, GRs, GSK-3β, GSH, HPA, IL, IR, iNOS, JNK, LTP, LPS, MAP2, MAPK, MCAO, MDA;, MDD, MQC, MPP, NAMPT, ND6, NE, NGF, NMDAR, nNOS, Nrf2, OBX, OGD, PD, PI3K, PTSD, ROS, 5-HT, SIRT1, SNpc, SOD, TH, TNF, WHO

Keywords : Psychiatric sequelae, Salidroside, Neuroprotection, Mental disorder, Neuroinflammation, Brain plasticity


Plan


© 2023  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 170

Article 115999- janvier 2024 Retour au numéro
Article précédent Article précédent
  • SIRT3 regulates mitochondrial function: A promising star target for cardiovascular disease therapy
  • Qin Zhang, Zhou Siyuan, Chang Xing, Liu Ruxiu
| Article suivant Article suivant
  • Bioactive substances of cyanobacteria and microalgae: Sources, metabolism, and anticancer mechanism insights
  • Abdelhakim Bouyahya, Saad Bakrim, Imane Chamkhi, Douae Taha, Nasreddine El Omari, Naoual El Mneyiy, Naoufal El Hachlafi, Mohamed El-Shazly, Asaad Khalid, Ashraf N. Abdalla, Khang Wen Goh, Long Chiau Ming, Bey Hing Goh, Tarik Aanniz

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.